Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Men with baldness are more prone to skin cancers on the scalp due to sun exposure, not testosterone.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Understanding hair biology is key to developing better treatments for hair and scalp issues.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Placental extracts have antioxidant, anti-inflammatory, and immune-boosting effects, but their exact workings are unclear.

EGFR inhibitors for lung cancer can cause severe skin issues.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Breast cancer alters specific molecular structures in hair, which revert after cancer removal.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

Keratinocyte stem cells are crucial for skin renewal and have potential in wound healing and tissue regeneration.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Early lung cancer screening in Ontario reduces deaths and is cost-effective.